Scott Tarriff, CEO at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 15,000 shares at $19.98 ($300K) on 2023-05-16, disclosed to the SEC on 2023-05-18.
Open-market sale of $300k EGRX by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EGRX | SELL | 2023-05-15 | $1.2M | — | Filing → |
| EGRX | SELL | 2019-04-03 | $2.5M | — | Filing → |
| EGRX | SELL | 2019-03-04 | $1.9M | — | Filing → |